<
AI
Automation
Science
Innovation
Open Source
Blockchain
Social Media
Startups
Culture
Cloud
>

Destination
Blocked From Selling Off-Brand Ozempic, Telehealth Startups Embrace a Less Effective Drug

As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 medication injected daily instead of weekly. [...]

Discover Copy
Rating

Innovation

Pricing

Technology

Usability

We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.

Destination
How Ozempic maker Novo Nordisk fell behind Eli Lilly in the weight loss drug race

Novo Nordisk (NVO) makes Ozempic, the best-known GLP-1 drug out today. And until quite recently, the Danish pharma giant consistently led the pack in new prescriptions, becoming virtually synonymous w [...]

Match Score: 68.65

venturebeat
Brand-context AI: The missing requirement for marketing AI

Presented by BlueOceanAI has become a central part of how marketing teams work, but the results often fall short. Models can generate content at scale and summarize information in seconds, yet the out [...]

Match Score: 48.13

Destination
8 key drug patents expiring soon — and what it means for the market

Nothing drives down a drug’s price like competition. According the U.S. Food and Drug Administration (FDA), a drug’s wholesale price drops by an average of 39% after just one generic competitor en [...]

Match Score: 47.48

Destination
Telehealth startup Medvi generated billions in revenue with AI-powered fake advertising

AI efficiency or AI fraud? How a two-person startup hit $1.8 billion in revenue with AI marketing and why the success story somewhat fell apart.<br /> The article Telehealth startup Medvi genera [...]

Match Score: 39.11

Destination
Wegovy's price cut, Amgen's Ozempic competitor, and Big Pharma's tax cut: Pharma news roundup

Novo Nordisk just cut the price of its weight-loss drug, Wegovy, by more than half for patients who pay without insurance. Amgen (AMGN) announced this week that it has begun two late-stage clinical tr [...]

Match Score: 38.07

qz
Hims & Hers will get to sell Ozempic. Like, real Ozempic. The stock soars 50%

Novo Nordisk and Hims had clashed on and off for months as the telehealth firm marketed compounded versions of Novo's blockbuster GLP-1 drug Wegovy [...]

Match Score: 36.64

Destination
Instagram blocked searches for #democrats and other political hashtags

Instagram blocked searches related to a number of political hashtags, including #democrats, #democrat, #jan6th, #republicans and a number of other terms Tuesday. Users who searched for these hashtags [...]

Match Score: 36.47

venturebeat
From lab to market: Rose Rock Bridge fast-tracks energy innovation in Tulsa

Presented by Tulsa Innovation LabsAs the global energy system evolves, companies are racing to adopt technologies that can deliver real-world solutions, especially in hard-to-abate industries. Oklahom [...]

Match Score: 35.80

thenextweb
Verdiva launches with $410M for weight loss drugs to challenge Ozempic, Wegovy

London-headquartered biotech startup Verdiva has emerged from stealth with a whopping $410mn for a new range of drugs aimed at tackling the obesity epidemic. It’s one of Europe’s largest-ever biot [...]

Match Score: 34.93